| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/DDG.13079 |
| P698 | PubMed publication ID | 27767268 |
| P50 | author | Nessa Aghazadeh | Q51757664 |
| P2093 | author name string | Maryam Daneshpazhooh | |
| Kamran Balighi | |||
| Cheyda Chams-Davatchi | |||
| Farzam Shahpouri | |||
| Pardis Hejazi | |||
| Vahide Saeidi | |||
| P2860 | cites work | Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice | Q33806970 |
| Severely suppressed bone turnover: a potential complication of alendronate therapy | Q33983792 | ||
| Glucocorticoid-induced osteonecrosis | Q34240713 | ||
| Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study | Q34372367 | ||
| Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? | Q35549358 | ||
| Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study | Q35637240 | ||
| American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis | Q37775935 | ||
| Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure | Q38288445 | ||
| Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study | Q41663457 | ||
| Avascular necrosis: a rare complication of steroid therapy for pemphigus | Q42124656 | ||
| Bilateral femoral avascular necrosis in a man with psoriasis: responsibility of topical corticosteroids and role of cyclosporine | Q43830458 | ||
| Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment | Q44110205 | ||
| Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. | Q45964358 | ||
| Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. | Q46526220 | ||
| Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. | Q51422493 | ||
| The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis. | Q53145049 | ||
| Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. | Q54652852 | ||
| Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research | Q58216587 | ||
| P433 | issue | 10 | |
| P921 | main subject | pemphigus | Q1483214 |
| Pemphigus vulgaris | Q10622783 | ||
| P304 | page(s) | 1016-1021 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | JDDG | Q15753048 |
| P1476 | title | Temporal course of avascular femoral head necrosis in patients with pemphigus vulgaris. | |
| P478 | volume | 14 |
Search more.